National Proficiency Testing of Molecular Diagnostics forTuberculosis and Drug Resistance Detection-China,2014-2019

作     者：Xichao Ou Hui Xia Shengfen Wang Bing Zhao Jiale Fan Yuanyuan Song Yang Zhou Yang Zheng Yanlin Zhao 

作者机构：National Center for Tuberculosis Control and PreventionChineseCenter for Disease Control and PreventionBeijingChina. 

出 版 物：《China CDC weekly》 (中国疾病预防控制中心周报（英文）)

年 卷 期：2021年第3卷第12期

页      面：247-251页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：国家科技重大项目 

主　　题：Tuberculosis diagnosis Molecular 

摘      要：Summary What is already known about this topic?Proficiency testing(PT)is a key component of qualityassurance and is essential in ensuring accuratelaboratory diagnosis of tuberculosis(TB)and drug-resistant *** National Tuberculosis ReferenceLaboratory(NTRL)developed a novel PT panel to testlaboratories’proficiency for molecular TB diagnosticassays throughout the TB laboratory network.A totalof 6 PT rounds for molecular diagnostics wereconducted by NTRL from 2014 to 2019.